X4 Pharmaceuticals OverviewX4 Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for XFOR.
Quarterly Other Income/Expense
$65000.00
↓ 99.33% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$1.97M
↓ 101.53% YoY
Trailing 12 months ending Mar 31, 2026